chrisvoncsefalvay/vaers-outcomes huggingface dataset:
passed away; dry, persistent cough; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (passed away) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not provided.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), UBIDECARENONE (COQ10 [UBIDECARENONE]), LISINOPRIL, METOPROLOL TARTRATE and OMEPRAZOLE for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced COUGH (dry, persistent cough) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. The patient died on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, COUGH (dry, persistent cough) and MYALGIA (Body aches) had not resolved.            This a case of death in 81-year-old male patient who received mRNA-1273. Very limited information regarding death (cause unknown) has been provided at this time. Further information has been requested. Based on the current available information and temporal association between the use of the product and the start date of the events cough and myalgia, a causal relationship cannot be excluded.  The event myalgia is consistent with the safety profile of the product.   This case was linked to MOD-2021-060909 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Contains patient death information.  Case upgraded to serious.; Sender's Comments: This a case of death in 81-year-old male patient who received mRNA-1273. Very limited information regarding death (cause unknown) has been provided at this time. Further information has been requested. Based on the current available information and temporal association between the use of the product and the start date of the events cough and myalgia, a causal relationship cannot be excluded.  The event myalgia is consistent with the safety profile of the product.; Reported Cause(s) of Death: unknown cause of death
Doses 1 and 2 were previously given  correctly. Dose 2 given on 07/22/2022. Pt. came in for her 3rd dose. This nurse mistakenly understood she was giving the 2nd dose. It was discovered today, 08/26/22,that this was pt's 3rd dose. 3rd dose was given 4 weeks early. Mother reports pt. did fine with the 3rd dose given on 08/19/22 except having a sore arm. Sore arm resolved and pt. is doing fine today, has done fine since 08/19/22.
Patient wanted to receive Fluzona HD, standard flu shot was administered in error. no adverse reactions besides patient wanted HD vaccine
I had my injection on a Monday, about 2:00pm,  5.5 hours after in the injection, I became aware that I had numbness in my face, arm and leg - more dominant on my left side.  On my face, more intense around my eye, nose & ear.  In my face, it was similar feeling to when one receives Novocain, and its beginning to wear off and give that pins & needle feeling.  In my arm and leg it was a general lack of sensitivity.  I knew I was touching my arm with a sharp object, but I could not feel or sense it.   I could walk, breath normal and talk.  I did not reach out for medical help at that point.  This lasted into the next day in all mentioned areas, the 3rd day (Wednesday) the only numbness that I was still aware of with out tapping to generate a stimulus, was in my face.  On Tuesday, 2/23/2021 - I had made a neurologist appointment to address the situation.  I still feel as if I have not completely regained sensation in my face and left arm, however I do need to tap on them to generate a stimulus response which feels somewhat numb. (Today is Thursday 3/4/2021 - 10 days after the 1st injection).
Mouth, tongue, gums, lips, cheeks (on outside) aching - slightly swollen but mostly pain which went into head, jaws & neck- throbbing inside mouth & taste buds didn't work - nite - aching & chills arm hurt swollen eyes, malaise, diarrhea abdominal pain dizziness.
Pt recv vax on 10/5/98; on 10/8/98 pt exp vax site redness, pain & a bump
Heart palpitations; shortness of breath; dizziness; hands shaken. Events lasted about 3 minutes. Then disappeared. They checked my blood pressure and it was elevated 155/110. High blood pressure remained for 2 days.
Patient reported full body itching. No hives/rash, no dsypnea. Patient reported at appointment for 2nd dose.
This is a spontaneous report from a contactable pharmacist. A 67-year-old female patient received on 22Sep2016 a single dose of PREVNAR 13, (lot number N16560, expiration date Sep2017, NDC number 00005197102) for immunization. Concomitant medications and medical history were not reported. On 22Sep2016, the patient had huge bruise  (around the size of the egg) in that area (thinking there was internal bleeding in the area) that was recovering and swollen up, that was recovered with lasting effects (Sep2016). Additionally it was reported that the patient experienced in Sep2016 pain in the area where the patient received the injection, still ongoing. The patient did not have a prescribing healthcare professional for the product. The pharmacist explained that no prescription is needed to receive pneumococcal 13-val conj vac (dipht crm197 protein) at the patient's age. The pharmacy gave the product without a prescription.
Narrative: COVID infection following COVID vaccine series 03/12, Pfizer, dose #1 04/05, Pfizer, dose #2 10/20 SARS-COV-2 Variant Sequencing result: pending 10/20 COVID swab, result: detected 10/16 pt cc: chills, diarrhea, fatigue exposure: unknown
Information has been received from a consumer who in January 2008, was vaccinated first dose of with GARDASIL (dose, route and lot number not provided).  The patient stated that after she received her first doseshe got a boil several of them.  It was not specified if the patient sought medical attention.  Additional information is not expected.
Fever hitting 100.1, chills, body aches, headache, left side of neck swollen lymph nodes, loss of appetite, very fatigue. I used tylenol 500 mg twice every 4-6 hours. Drank plenty of water and Orange Juice.
Positive pregnancy test 01/01/2021; Vaginal spotting, no fetal heart tones found at first OB appointment, 01/18/2021. No fetal heart tones at follow up appointment on 02/04/2021. No fetal heart tones found 02/22/2021. Tissue passed resulting in confirmed miscarriage 02/23/2021.  Est delivery date 09/2021.  Following ectopic pregnancy diagnosed 05/07/2021.  1 living child born 02/2018 at 37 weeks gestation r/t preeclampsia; no other pregnancy complications.
Pt felt a strange feeling in throat with mild difficulty swallowing. I gave 12.5 mg of benadryl and improved but not completely. Gave another 12.5 of benadryl about 15-20 mins later and  he improved.
Within 2-3 minutes, developed tachycardia followed by acute onset shortness of breath, wheezing, hives/angioedema of the face requiring immediate emergency department visit and treatment. Syndrome was consistent with anaphylaxis.
Subarachnoid hemorrhage on 4/20/21. She began complaining of strong pain that caused vomiting, swelling, and hospital visits from about 3 weeks ago.  We thought it was her blood pressure but it was consistently normal.  She described it as the worst pain she has ever felt.
I received the vaccination on Monday afternoon.  No trouble that night or during the next day.  About 5:00 pm Tuesday, running errands after work I began to feel ill.  I had GI cramps and assumed I just need to get to a bathroom.   The continued to get worse throughout the evening and night.  I did not go to work the next day.  Instead I slept and laid in bed most of the day.  I had some diarrhea.  I may have vomited, I don't remember.  My wife said later she was "surprised that you had so much abdominal distress."
light headed  chills muscle hurts lathargic  this one is worst than the last time. Taken to the ER 2 days after. They think its vertigo. The minute the selling went down on my arm the  light headed went away and my arm was really red.   ER info: just there for 6 hrs
Day following vaccine, patient's legs started hurting, hips, bones, and severe headache by end of day.  Tues. night had severe chills and shaking with approx. 3in in diameter red lump at injection site.
MOM NOTICED THE L THIGH WAS RED/SWOLLEN/HOT. NO PAIN TO TOUCH THE AREA FLAT AND WIDE ABOUT 7-8" WIDE. THE REDNESS IS TO HIS KNEE, DOESN'T GO ALL THE WAY AROUND THE LEG. DOES NOT SEEM TO BOTHER HIM
Pt recvd 2nd dose of Engerix-B on 3OCT91; 22 days later pt devel urticaria, polyarthralgia & hypothyroidism; pt was hositalized; MD stated that relationship to vax was "doubtful";
Broke out in hives on 8/7/2022.  Required several courses of prednisone and numerous antihistamines to gain control.  Ultimately diagnosed with chronic idiopathic urticaria.  Still has mild episodes of hives intermittently.
RECEIVED VACCINE 10//18/05 P.M. FAMILY STATES NO UNTOWARD AFFECTS NOTD PAST IMMUNIZATION.  FOUND IN BED DEAD THE 11/19/2005 A.M. Drug Toxicity added from Autopsy report rec'd 12/08/2005 was + for methadone & ETOH.  Parent admitted to administering adult strength Tylenol to patient./sr
Patient received her vaccine and was taken to the observation area to be observed for a 15-minute period. In the observation area, she immediately reported "feeling funny" and was noted to be "sweaty". The advanced practice nurses and pharmacist were called for assistance immediately. She was placed on a stretcher, had her legs elevated, and was moved to a quieter area. She was responsive to commands and her vitals at this time were as follows: blood pressure 96/56 mm Hg, oxygen saturation of 96%, and heart rate in mid 60s.  She did not require treatment and within several minutes of lying down on the stretcher felt better. She did not have any rashes or swelling, and she denied difficulty breathing. She was observed for about half an hour in this area and was also evaluated Emergency Medical Services who had been called. It was suggested that the patient should visit the Emergency Department for observation but she refused as she felt better and due to concerns of being exposed to Covid-19. We were able to walk with her escort her to the exit area at the end of the observation period.   We questioned her about potential allergies again and she denied a history of allergic reactions. The advanced practice nurse evaluating the patient suggested this episode was consistent with a vasovagal episode and that anxiety could have also played a role.
Information has been received from a consumer concerning her 9 year old daughter who has no pre-existing medical history, and who on 5/26/95 was vaccinated SC with a first dose of varicella virus vaccine live (lot # 608581/0409B). There was no concomitant medication. It was reported that as of 4/11/03 the patient has been diagnosed with active chicken pox. It was reported that the patient had 25 pox on her face and neck, 9 on her back, 21 on her stomach and chest, and 15 on her legs for a total of 70. It was noted that the patient's mother feels this is a mild case because the pox are small in diameter, and her daughter isn't scratching or too bothered. Follow up information received from a nurse practitioner indicated that the chicken pox event onset date was 4/10/03 and the diagnosis of active chicken pox was on 4/11/03. The nurse practitioner reported she had seen the patient for her chicken pox and noted, the event was not a reaction to vaccine, vaccine given years before event. It was reported there were no laboratory tests performed. It was also reported the patient was not ill at the time of vaccination, and she has not had an adverse event following prior vaccination. Subsequently, the patient recovered.
Pt was in for shots at approx. 10:50. No adverse reaction noted after shots. At approx. 16:30, the mother called stating "my child has a rash on the back of his neck and stomach". I instructed her to take the child to an MD or ER for evaluation. Mother agreed to do so. On 2/23/02, mother called and stated that pt was fine but has started to break out again.
Patient fainted in waiting room chair while waiting for the 15 minutes post-vaccine. Patient was pale and stated she didn't feel well to her companion, then fainted. Her companion caught her to prevent her from falling out of the chair and notified the pharmacist that a reaction was occurring.  The patient  regained consciousness several seconds later and responded "yes" when the pharmacist asked if she'd like us to call 911. The pharmacist took her blood pressure with an automated cuff and it was 103/59 mmHg, pulse 54 bpm. EMS arrived quickly and took charge of patient. EMS took her BP sitting and standing, applied EKG pads, and removed patient from the store. Bystander hearsay was that the patient then refused to go to the hospital because she did not have insurance.
11 hours after?intense shivering shuddering 22 hours after, awoke to?shivering, sweating, dizziness, lightheadedness, inability to get out of bed, dry heaves 23 hours after?attempted to get out of bed, fell/collapsed/fainted sustained many bruises
This spontaneous report was received from a physician refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX23 (lot#, dose and route not reported). No concomitant medications were reported. On an unknown date, the patient experienced pain in her jaw after receiving PNEUMOVAX23. She also had a questionable enlarged lymph node in the throat area. No treatment was received. The patient sought medical attention(contacted the HCP). No laboratory diagnostics studies were performed. The outcome of pain in her jaw and enlarged lymph node in the throat area was reported as recovered. Additional information has been requested.
Left upper thigh bright red with extension to below the knee, with mild swelling. Redness was slight at time of exam-no swelling.
Immediate severe burning at site. Within proximately five minutes it was followed by a red dime sized nodule. A few hours later: red-swelling, pain, and a severe burning sensation. Area is hot to touch, darker-red & swollen. The injection site (red-area) continued spreading. It progressed to an adult palm sized round painful red-purple-ish area with a larger nodule. The redness continues to grow and burn after three days.
My mild tinnitus overnight has been amplified to an unbearable loud constant hissing. Can?t sleep, the sound is literally unbearable.
Delayed reaction to Moderna mRNA vaccine 2nd dose. No problems with 1st vaccine. 12 hours post injection - Flushing, increased HR, tight throat, nausea, no emesis. Took baseline Zyrtec and monteulkast. Had not had a mast cell flare since 2019. Presented to the ER with HR 129, elevated BP, flushing, diffuse erythema. Treated with solumedrol, IV fluids, Zofran, diphenhydramine 50mg. Discharged home on oral prednisone.
Patient reported feeling anxious, cold and dizzy about 5 minutes post vaccination . Patient started to sweat (sweat was vissible on his forehead & his shirt). I escorted patient to immunization booth and assited him to lie down on his back (supine) as recommended per immunization adverse event response protocol. I applied cold compresses to his forhead and arms, monitored his breathing, LOC and BP until emergency response team arrived. By the time emergency response arrived, the patient stated he felt better. He declined ambulance and decided to drive himself home. Both the emergency response team and the patient left the pharmacy.
This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE CYST (big liquid blob), VACCINATION SITE SWELLING (swelling in her left arm) and VACCINATION SITE PRURITUS (itchy) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE CYST (big liquid blob), VACCINATION SITE SWELLING (swelling in her left arm) and VACCINATION SITE PRURITUS (itchy). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, INJECTION SITE CYST (big liquid blob), VACCINATION SITE SWELLING (swelling in her left arm) and VACCINATION SITE PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment for the event included Advil (Ibuprofen)
worry about dying; on and off again not to much appetite; he is in a lot of pain; definitely a high fever of 104°F/High temperature; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (worry about dying), DECREASED APPETITE (on and off again not to much appetite), PAIN (he is in a lot of pain) and PYREXIA (definitely a high fever of 104°F/High temperature) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (worry about dying), DECREASED APPETITE (on and off again not to much appetite), PAIN (he is in a lot of pain) and PYREXIA (definitely a high fever of 104°F/High temperature). At the time of the report, ANXIETY (worry about dying), DECREASED APPETITE (on and off again not to much appetite) and PAIN (he is in a lot of pain) outcome was unknown and PYREXIA (definitely a high fever of 104°F/High temperature) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104 (High) high fever of 104°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Cellulitis (R) arm tx: Augmentin 875mg PO BIDx5-7d. warm compresses
arm swelled up; arm turned red; arm was hot; arm itched on and off; Injection site still 3-4-inch mark; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included High cholesterol, Penicillin allergy, Drug allergy (atorvastatin, cefdinir, diclofenac, meloxicam, zoster vaccine, amoxicillin, Biaxin, codeine, penicillin, Levaquin, levofloxacin, doxycycline, nitrofurantoin and carisoprodol), Allergy to antibiotic and Allergy to vaccine.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark). At the time of the report, PERIPHERAL SWELLING (arm swelled up), ERYTHEMA (arm turned red), SKIN WARM (arm was hot), PRURITUS (arm itched on and off) and VACCINATION SITE RASH (Injection site still 3-4-inch mark) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Bruise at the injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Bruise at the injection site) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE BRUISING (Bruise at the injection site) and FATIGUE (Fatigue). On 24-Jan-2021, FATIGUE (Fatigue) had resolved. On 28-Jan-2021, VACCINATION SITE BRUISING (Bruise at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
extreme fatigue followed by a sudden onset of diarrhea which cleared up within a few hours. No treatment was required though I did avoid eating for a few hours
pt recv vax approx 10-11AM 25JUL;by afternoon had chills, temp, aching, pain in eyes;temp gone on 28JUL but cont aching, extreme fatigue, pain in eyes, joint & muscle pain-severe;sent to MD 29JUL because of cont severe discomfort;
No adverse effect reported.; the patient was inadvertently administered a dose of VAQTA (Lot#R024007/Exp:10/12/2019), that was expired; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information about the patient's concurrent conditions, pertinent medical history, previous drug reactions or allergies and concomitant medications was not provided.  It was reported that on 23-OCT-2019, the patient was inadvertently vaccinated with hepatitis a vaccine, inactivated (VAQTA) 20/0.5 (units not provided) for prophylaxis (dose number, route of administration and anatomical location of vaccination were not provided; lot number R024007 has been verified to be valid; expiration date 12-OCT-2019), that was expired (expired product administered).  No adverse effect was reported.
VACCINE ADMINISTERED TO TWO PATIENTS WAS AT ROOM TEMPERATURE FOR FOUR HOURS; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned multiple patients.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 04-AUG-2021) dose was not reported, administered on 01-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-JUL-2021, the subject experienced vaccine administered to two subjects was at room temperature for four hours. On 01-JUL-2021, the subject experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine administered to two patients was at room temperature for four hours and incorrect product storage was not reported. This report was non-serious.
My health record does not state the brand/manufacturer of my influenza vaccine.  Instead, it states: INFLUENZA, INJECTABLE, QUADRIVALENT, PRESERVATIVE FREE. Four hours after my injection I began experiencing severe flu-like symptoms that continued in waves over the next 3 days, peaking between 11pm and 2am, then waning again in the mornings. Temperatures spiked above 101 (considerably high given my baseline is very low at ~96.8), then nightsweats would break out and my temperature drops went into the 94.2-94.8 by mid-morning. In addition to fever, chills, severe nightsweats, constant headache, waves of body aches, pulse ox dips to 95 (my baseline is 99), I also experienced resting heart rates (my baseline is 50) in the 70 and 80 range. Note: I did a covid test (negative) after 2 days of symptoms to rule it out, even though I am fully vaxxed.
Arm became sore per usual vaccine reaction but got worse as the days went on.  The redness is now taken my entire upper 1/2 of my arm and the pain goes down the arm to the hand.  There has been swelling foe the last 2 days even with using ice packs and Ibuprofen.